Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyceraldehyde 3-phosphate dehydrogenase mRNA (GAPDH mRNA) is the messenger RNA transcript encoding the enzyme glyceraldehyde 3-phosphate dehydrogenase. This transcript is widely expressed in human tissues and has traditionally been used as a housekeeping or reference sequence for normalization in quantitative PCR and other molecular biology assays due to its presumed stable expression. However, recent research shows that GAPDH mRNA levels vary significantly between tissue types, pathological conditions such as cancer, aging, and neurodegenerative diseases. High levels of GAPDH mRNA are associated with poor prognosis in several cancers[2]. The presence of numerous pseudogenes complicates its use as a specific assay target because these pseudogenes can be co-amplified during PCR-based detection[4]. While not itself considered a therapeutic target like an enzyme or receptor, it serves an important role as a biomarker for experimental controls and sometimes for disease prognosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glyceraldehyde 3-phosphate dehydrogenase mRNA (GAPDH mRNA).